B.Riley Assumes OptimizeRX (OPRX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts OPRX Hot Sheet
Price: $9.06 -0.11%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 8 | New: 3
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 8 | New: 3
Join SI Premium – FREE
B.Riley analyst Marc Wisenberger assumes coverage on OptimizeRX (NASDAQ: OPRX) with a Buy rating and a price target of $102.00.
For an analyst ratings summary and ratings history on OptimizeRX click here. For more ratings news on OptimizeRX click here.
Shares of OptimizeRX closed at $84.62 yesterday.
You May Also Be Interested In
- OptimizeRX (OPRX) Reiterated at Market Outperform by Citizens Amid Headwinds, Revenue Decline
- JPMorgan Assumes Airtac International (1590:TT) at Overweight
- Goldman Sachs Reinstates Poste Italiane SpA (PST:IM) (PITAF) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
